Understanding the heterogeneity and relative deficiency of endogenous BNP in ADHF may improve the interpretation of point-of-care tests and clinical management.
No takes yet. Share an insight, caveat, or question.
May improve BNP assay interpretation and ADHF management; leaves open prospective validation of resistance mechanisms.
Hobbs et al. (2008) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: